Literature DB >> 27707963

Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis.

Genevieve Beauvais1, Nicole M Bode2, Jaime L Watson1, Hsiang Wen3, Kevin A Glenn3, Hiroyuki Kawano4, N Charles Harata4, Michelle E Ehrlich5, Pedro Gonzalez-Alegre6.   

Abstract

Dystonia type 1 (DYT1) is a dominantly inherited neurological disease caused by mutations in TOR1A, the gene encoding the endoplasmic reticulum (ER)-resident protein torsinA. Previous work mostly completed in cell-based systems suggests that mutant torsinA alters protein processing in the secretory pathway. We hypothesized that inducing ER stress in the mammalian brain in vivo would trigger or exacerbate mutant torsinA-induced dysfunction. To test this hypothesis, we crossed DYT1 knock-in with p58(IPK)-null mice. The ER co-chaperone p58(IPK) interacts with BiP and assists in protein maturation by helping to fold ER cargo. Its deletion increases the cellular sensitivity to ER stress. We found a lower generation of DYT1 knock-in/p58 knock-out mice than expected from this cross, suggesting a developmental interaction that influences viability. However, surviving animals did not exhibit abnormal motor function. Analysis of brain tissue uncovered dysregulation of eiF2α and Akt/mTOR translational control pathways in the DYT1 brain, a finding confirmed in a second rodent model and in human brain. Finally, an unbiased proteomic analysis identified relevant changes in the neuronal protein landscape suggesting abnormal ER protein metabolism and calcium dysregulation. Functional studies confirmed the interaction between the DYT1 genotype and neuronal calcium dynamics. Overall, these findings advance our knowledge on dystonia, linking translational control pathways and calcium physiology to dystonia pathogenesis and identifying potential new pharmacological targets. SIGNIFICANCE STATEMENT: Dystonia type 1 (DYT1) is one of the different forms of inherited dystonia, a neurological disorder characterized by involuntary, disabling movements. DYT1 is caused by mutations in the gene that encodes the endoplasmic reticulum (ER)-resident protein torsinA. How mutant torsinA causes neuronal dysfunction remains unknown. Here, we show the behavioral and molecular consequences of stressing the ER in DYT1 mice by increasing the amount of misfolded proteins. This resulted in the generation of a reduced number of animals, evidence of abnormal ER protein processing and dysregulation of translational control pathways. The work described here proposes a shared mechanism for different forms of dystonia, links for the first time known biological pathways to dystonia pathogenesis, and uncovers potential pharmacological targets for its treatment.
Copyright © 2016 the authors 0270-6474/16/3610245-12$15.00/0.

Entities:  

Keywords:  dystonia; eif2alpha; endoplasmic reticulum; p58; proteomics; torsina

Mesh:

Substances:

Year:  2016        PMID: 27707963      PMCID: PMC5050323          DOI: 10.1523/JNEUROSCI.0669-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Endoplasmic reticulum stress during the embryonic development of the central nervous system in the mouse.

Authors:  Xiaochu Zhang; Eva Szabo; Marek Michalak; Michal Opas
Journal:  Int J Dev Neurosci       Date:  2007-08-26       Impact factor: 2.457

2.  Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.

Authors:  Renu Wadhwa; Jihoon Ryu; Hyo Min Ahn; Nishant Saxena; Anupama Chaudhary; Chae-Ok Yun; Sunil C Kaul
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

3.  A unique redox-sensing sensor II motif in TorsinA plays a critical role in nucleotide and partner binding.

Authors:  Li Zhu; Linda Millen; Juan L Mendoza; Philip J Thomas
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

4.  Structural insight into the protective role of P58(IPK) during unfolded protein response.

Authors:  Jiahui Tao; Bingdong Sha
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

5.  Exploring the influence of torsinA expression on protein quality control.

Authors:  Kara L Gordon; Kevin A Glenn; Pedro Gonzalez-Alegre
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

6.  ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.

Authors:  Laurence Suaud; Katelyn Miller; Lora Alvey; Wusheng Yan; Amal Robay; Catherine Kebler; James L Kreindler; Susan Guttentag; Michael J Hubbard; Ronald C Rubenstein
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

7.  Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.

Authors:  Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

8.  TorsinA participates in endoplasmic reticulum-associated degradation.

Authors:  Flávia C Nery; Ioanna A Armata; Jonathan E Farley; Jin A Cho; Uzma Yaqub; Pan Chen; Cintia Carla da Hora; Qiuyan Wang; Mitsuo Tagaya; Christine Klein; Bakhos Tannous; Kim A Caldwell; Guy A Caldwell; Wayne I Lencer; Yihong Ye; Xandra O Breakefield
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

9.  Functional characterization of 58-kilodalton inhibitor of protein kinase in protecting against diabetic retinopathy via the endoplasmic reticulum stress pathway.

Authors:  Hong Yang; Rong Liu; Zheng Cui; Zhi-Qi Chen; Shu Yan; Han Pei; Bin Li
Journal:  Mol Vis       Date:  2011-01-10       Impact factor: 2.367

10.  A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia.

Authors:  Stephan J Guyenet; Stephanie A Furrer; Vincent M Damian; Travis D Baughan; Albert R La Spada; Gwenn A Garden
Journal:  J Vis Exp       Date:  2010-05-21       Impact factor: 1.355

View more
  12 in total

1.  TorsinA dysfunction causes persistent neuronal nuclear pore defects.

Authors:  Samuel S Pappas; Chun-Chi Liang; Sumin Kim; CheyAnne O Rivera; William T Dauer
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

2.  TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia.

Authors:  Jay Li; Daniel S Levin; Audrey J Kim; Samuel S Pappas; William T Dauer
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 3.  Emerging and converging molecular mechanisms in dystonia.

Authors:  Paulina Gonzalez-Latapi; Nicolas Marotta; Niccolò E Mencacci
Journal:  J Neural Transm (Vienna)       Date:  2021-01-01       Impact factor: 3.575

Review 4.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

5.  A truncated PACT protein resulting from a frameshift mutation reported in movement disorder DYT16 triggers caspase activation and apoptosis.

Authors:  Samuel B Burnett; Lauren S Vaughn; Joelle M Strom; Ashley Francois; Rekha C Patel
Journal:  J Cell Biochem       Date:  2019-06-27       Impact factor: 4.429

6.  The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia.

Authors:  Zachary F Caffall; Bradley J Wilkes; Ricardo Hernández-Martinez; Joseph E Rittiner; Jennifer T Fox; Kanny K Wan; Miranda K Shipman; Steven A Titus; Ya-Qin Zhang; Samarjit Patnaik; Matthew D Hall; Matthew B Boxer; Min Shen; Zhuyin Li; David E Vaillancourt; Nicole Calakos
Journal:  Sci Transl Med       Date:  2021-08-18       Impact factor: 17.956

7.  DYT-PRKRA Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon Induction.

Authors:  Lauren S Vaughn; Kenneth Frederick; Samuel B Burnett; Nutan Sharma; D Cristopher Bragg; Sarah Camargos; Francisco Cardoso; Rekha C Patel
Journal:  Biomolecules       Date:  2022-05-17

8.  The abnormal firing of Purkinje cells in the knockin mouse model of DYT1 dystonia.

Authors:  Yuning Liu; Hong Xing; Bradley J Wilkes; Fumiaki Yokoi; Huanxin Chen; David E Vaillancourt; Yuqing Li
Journal:  Brain Res Bull       Date:  2020-09-22       Impact factor: 4.077

9.  Mutant torsinA in the heterozygous DYT1 state compromises HSV propagation in infected neurons and fibroblasts.

Authors:  Bence György; Lilian Cruz; David Yellen; Massimo Aufiero; Isabel Alland; Xuan Zhang; Maria Ericsson; Cornel Fraefel; Yu-Ching Li; Shuko Takeda; Bradley T Hyman; Xandra O Breakefield
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

10.  Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE.

Authors:  Lucía F Zacchi; John C Dittmar; Michael J Mihalevic; Annette M Shewan; Benjamin L Schulz; Jeffrey L Brodsky; Kara A Bernstein
Journal:  Dis Model Mech       Date:  2017-08-02       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.